# Histiocytic Disorders and Treatments
**Type:** Topics
**Canonical URL:** https://scholariq.org/topics/histiocytic-disorders-and-treatments/
## Facts
| Field | Value |
| --- | --- |
| Description | This cluster of papers focuses on the classification, diagnosis, and treatment of histiocytic disorders, including Langerhans Cell Histiocytosis and Erdheim-Chester Disease. It explores the role of BRAF mutations, immunohistochemical approaches to classification, and consensus guidelines for clinical management. The papers also delve into the pathogenesis, molecular characterization, and therapy intensification for multisystem involvement. |
| Domain | Health Sciences |
| Field | Medicine |
| OpenAlex ID | t11909 |
| Works | 70 |
## Topic papers all
Showing 15 of 70.
- [Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease \[see comments\]](https://scholariq.org/papers/kaposi-s-sarcoma-associated-herpesvirus-like-dna-sequences-in-multicentric/)
- [Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages](https://scholariq.org/papers/revised-classification-of-histiocytoses-and-neoplasms-of-the-macrophage/)
- [Humanized anti–interleukin-6 receptor antibody treatment of multicentric Castleman disease](https://scholariq.org/papers/humanized-anti-interleukin-6-receptor-antibody-treatment-of-multicentric/)
- [Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma](https://scholariq.org/papers/human-mesenchymal-stem-cells-exert-potent-antitumorigenic-effects-in-a-model-of/)
- [High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses](https://scholariq.org/papers/high-prevalence-of-braf-v600e-mutations-in-erdheim-chester-disease-but-not-in/)
- [Langerhans cell histiocytosis (LCH): Guidelines for diagnosis, clinical work‐up, and treatment for patients till the age of 18 years](https://scholariq.org/papers/langerhans-cell-histiocytosis-lch-guidelines-for-diagnosis-clinical-work-up-and/)
- [Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease](https://scholariq.org/papers/consensus-recommendations-for-the-diagnosis-and-clinical-management-of-rosai/)
- [Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma](https://scholariq.org/papers/synergy-between-basic-fibroblast-growth-factor-and-hiv-1-tat-protein-in/)
- [Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma](https://scholariq.org/papers/epstein-barr-virus-in-nasal-t-cell-lymphomas-in-patients-with-lethal-midline/)
- [Clinical Outcomes of Pulmonary Langerhans'-Cell Histiocytosis in Adults](https://scholariq.org/papers/clinical-outcomes-of-pulmonary-langerhans-cell-histiocytosis-in-adults/)
- [Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model](https://scholariq.org/papers/cutaneous-lymphoma-international-consortium-study-of-outcome-in-advanced-stages/)
- [Sturge-Weber syndrome: A review](https://scholariq.org/papers/sturge-weber-syndrome-a-review/)
- [Risk factors for diabetes insipidus in langerhans cell histiocytosis](https://scholariq.org/papers/risk-factors-for-diabetes-insipidus-in-langerhans-cell-histiocytosis/)
- [Deregulation of cell growth by the K1 gene of Karposi's sarcoma-associated herpesvirus](https://scholariq.org/papers/deregulation-of-cell-growth-by-the-k1-gene-of-karposi-s-sarcoma-associated/)
- [Juvenile xanthogranuloma: Forms of systemic disease and their clinical implications](https://scholariq.org/papers/juvenile-xanthogranuloma-forms-of-systemic-disease-and-their-clinical/)
## Topic primary papers
Showing 15 of 38.
- [Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages](https://scholariq.org/papers/revised-classification-of-histiocytoses-and-neoplasms-of-the-macrophage/)
- [High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses](https://scholariq.org/papers/high-prevalence-of-braf-v600e-mutations-in-erdheim-chester-disease-but-not-in/)
- [Langerhans cell histiocytosis (LCH): Guidelines for diagnosis, clinical work‐up, and treatment for patients till the age of 18 years](https://scholariq.org/papers/langerhans-cell-histiocytosis-lch-guidelines-for-diagnosis-clinical-work-up-and/)
- [Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease](https://scholariq.org/papers/consensus-recommendations-for-the-diagnosis-and-clinical-management-of-rosai/)
- [Clinical Outcomes of Pulmonary Langerhans'-Cell Histiocytosis in Adults](https://scholariq.org/papers/clinical-outcomes-of-pulmonary-langerhans-cell-histiocytosis-in-adults/)
- [Risk factors for diabetes insipidus in langerhans cell histiocytosis](https://scholariq.org/papers/risk-factors-for-diabetes-insipidus-in-langerhans-cell-histiocytosis/)
- [Juvenile xanthogranuloma: Forms of systemic disease and their clinical implications](https://scholariq.org/papers/juvenile-xanthogranuloma-forms-of-systemic-disease-and-their-clinical/)
- [The clinical spectrum of Erdheim-Chester disease: an observational cohort study](https://scholariq.org/papers/the-clinical-spectrum-of-erdheim-chester-disease-an-observational-cohort-study/)
- [Rosai-Dorfman Disease: Tumor Biology, Clinical Features, Pathology, and Treatment](https://scholariq.org/papers/rosai-dorfman-disease-tumor-biology-clinical-features-pathology-and-treatment/)
- [Frequent detection of BRAFV600E mutations in histiocytic and dendritic cell neoplasms](https://scholariq.org/papers/frequent-detection-of-scp-i-braf-i-sup-v-sup-scp-sup-600e-sup-mutations-in/)
- [Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study](https://scholariq.org/papers/cladribine-and-cytarabine-in-refractory-multisystem-langerhans-cell/)
- [Histiocytic disorders](https://scholariq.org/papers/histiocytic-disorders/)
- [Pulmonary Langerhans Cell Histiocytosis](https://scholariq.org/papers/pulmonary-langerhans-cell-histiocytosis/)
- [Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman disease](https://scholariq.org/papers/clofarabine-salvage-therapy-in-refractory-multifocal-histiocytic-disorders/)
- [Langerhans cell histiocytosis in neonates](https://scholariq.org/papers/langerhans-cell-histiocytosis-in-neonates/)
---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.